Ariana® Pharma teams together with SIB Swiss Institute of Bioinformatics to discover novel biomarkers for gastric cancer

Ariana Pharma, developer of innovative clinical data analysis and diagnostic solutions for the healthcare sector, and SIB Swiss Institute of Bioinformatics, a world-class provider of bioinformatics resources and expertise, today announced their collaboration focusing on the discovery of novel biomarkers for gastric cancer.

Read more ...

Study Examines Association of Genetic Variants with Cognitive Impairment

Individually rare but collectively common intermediate-size copy number variations may be negatively associated with educational attainment, according to a study in the May 26 issue of JAMA. Copy number variations (CNVs) are regions of the genome that differ in the number of segments of DNA.

Read more ...

ELIXIR accelerates with major Horizon 2020 funding

ELIXIR has been awarded €19 million from the EU to accelerate the implementation of Europe’s life-science data infrastructure over the next four years. From September 2015, ‘ELIXIR-EXCELERATE’ will facilitate the integration of Europe’s bioinformatics resources, supporting all sectors of life-science R&D. It will deliver excellence to ELIXIR’s users by fast-tracking the development and deployment of essential data services.

Read more ...

GTEx - How DNA differences influence gene activity and disease

Researchers co-led by Emmanouil Dermitzakis, geneticist at the University of Geneva (UNIGE) Faculty of Medicine and at the SIB Swiss Institute of Bioinformatics, have created a new and much-anticipated data resource to help them find out how differences in an individual’s genetic make-up can affect gene activity and contribute to disease.

Read more ...
Page 3 of 4

Press contact

marie dangles
Marie Dangles
Head of Communications

maia berman
Maïa Berman
Communications Manager

sylvie clottu
Sylvie Clottu
Communications Assistant
 

SIB Communications
communication@sib.swiss
+41 21 692 40 46